B-cell development in man.

P D Burrows; M D Cooper

doi:10.1016/0952-7915(93)90005-d

Home/Archive/PubMed

PubMed · 7685171

B-cell development in man.

P D Burrows·M D Cooper

View original source ↗Export metadata ↓

Abstract

The development of B-lineage cells requires a series of complex interactions with hemopoietic stromal cell elements during the generative phase, and with antigen and T lymphocytes during the subsequent proliferative/differentiative phases in lymphoid tissues. Recent advances have been made in defining developmental changes in structure and assembly of the antigen receptors and in identifying protein kinases involved in signal transduction via these receptors. The mechanism of T-cell help has also come into much clearer focus through elucidation of the interaction between CD40 on B cells and the CD40 ligand on activated T cells. Finally, progress has been made with the recent identification of defects in a cytoplasmic protein tyrosine kinase and in the CD40 ligand as causes of two B-cell immunodeficiencies in man.

Explore related subjects

Antigens, CD Antigens, Differentiation, B-Lymphocyte B-Lymphocytes CD40 Antigens Gene Rearrangement, B-Lymphocyte Humans Immunologic Deficiency Syndromes Lymphocyte Cooperation Receptors, Antigen, B-Cell Signal Transduction Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S.Review

Keep this discovery

Explore connections, maps & timelines

BibTeX RIS

P D Burrows, M D Cooper. 1993. B-cell development in man.. https://doi.org/10.1016/0952-7915(93)90005-d

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

PubMed2004

p38 MAP kinase regulates rapid matrix metalloproteinase-9 release from eosinophils.

Eosinophils constitutively produce and store matrix metalloproteinase-9 (MMP-9), a protease implicated in tissue remodeling observed in asthma. In this study, we examined the rapid release of stored MMP-9 from eosinophils following stimulation with either tumor necrosis factor-alpha (TNF-alpha or the bacterial product fMLP. TNF-alpha induced rapid and robust pro-MMP-9 release from eosinophils. MMP-9 could be detected in the cell-free supernatant as early as 15min after stimulation. Rapid MMP-9 release was similarly induced by fMLP. TNF-alpha stimulation activated the mitogen-activated protein (MAP) kinases p38 MAP kinase and extracellular signal-regulated kinase-2 (Erk-2) at times and concentrations similar to that observed for MMP-9 release. Using pharmacological inhibitors, we found that TNF-alpha-stimulated MMP-9 release was mediated by p38 MAP kinase, but not Erk-1/2. Signaling through p38 MAP kinase may represent a universal mechanism for MMP-9 release from eosinophils, as fMLP-induced MMP-9 release was also regulated by p38 MAP kinase.

Antigens, CD↗

PubMed2004

Transferrin's mechanism of interaction with receptor 1.

The kinetics and thermodynamics of the interactions of transferrin receptor 1 with holotransferrin and apotransferrin in neutral and mildly acidic media are investigated at 37 degrees C in the presence of CHAPS micelles. Receptor 1 interacts with CHAPS in a very fast kinetic step (<1 micros). This is followed in neutral media by the interaction with holotransferrin which occurs in two steps after receptor deprotonation, with a proton dissociation constant (K(1a)) of 10.0 +/- 1.5 nM. The first step is detected by the T-jump technique and is associated with a molecular interaction between the receptor and holotransferrin. It occurs with a first-order rate constant (k(-1)) of (1.6 +/- 0.2) x 10(4) s(-1), a second-order rate constant (k(1)) of (3.20 +/- 0.2) x 10(10) M(-1) s(-1), and a dissociation constant (K(1)) of 0.50 +/- 0.07 microM. This step is followed by a slow change in the conformation with a relaxation time (tau(2)) of 3400 +/- 400 s and an equilibrium constant (K(2)) of (4.6 +/- 1.0) x 10(-3) with an overall affinity of the receptor for holotransferrin [(K'1)(-1)] of (4.35 +/- 0.60) x 10(8) M(-1). Apotransferrin does not interact with receptor 1 in neutral media, between pH 4.9 and 6, it interacts with the receptor in two steps after a receptor deprotonation (K(2a) = 2.30 +/- 0.3 microM). The first step occurs in the range of 1000-3000 s. It is ascribed to a slow change in the conformation which rate-controls a fast interaction between apotransferrin and receptor 1 with an overall affinity constant [(K(3))(-1)] of (2.80 +/- 0.30) x 10(7) M(-1). These results imply that receptor 1 probably exists in at least two forms, the neutral species which interacts with holotransferrin and not with apotransferrin and the acidic species which interacts with apotransferrin. At first, the interaction of the neutral receptor with holotransferrin is extremely fast. It is followed by the slow change in conformation, which leads to an important stabilization of the thermodynamic structure. In the acidic media of the endosome, the interaction of apotransferrin with the acidic receptor is sufficiently strong and rate-controlled by a very slow change in conformation which allows recycling back to the plasma membrane.

Antigens, CD↗

PubMed2004

Direct cell-cell interaction enhances pro-MMP-2 production and activation in co-culture of laryngeal cancer cells and fibroblasts: involvement of EMMPRIN and MT1-MMP.

Matrix metalloproteinases-2 (MMP-2, gelatinase A) has been regarded as a crucial enzyme for tumor progression, invasion, and metastasis by its capability to degrade the basement membrane components, and its activation process is critical for tumor development. Recently, EMMPRIN/CD147, which is a member of immunoglobulin superfamily, has been reported to be highly expressed in tumor cells and induce production of MMPs from fibroblasts adjacent to the tumor cells. In this study, we demonstrated that production of pro- and active forms of MMP-2 by human dermal fibroblasts was enhanced by the direct cell-cell contact with co-cultured HEp-2 cells derived from a human laryngeal epidermoid carcinoma. The results from immunoblotting and reverse transcription-polymerase chain reaction (RT-PCR) analysis indicated that HEp-2 cells express a higher level of EMMPRIN but only a low level of MMP-2 and membrane type 1-matrix metalloproteinase (MT1-MMP), whereas fibroblasts express a higher level of MMP-2 and MT1-MMP and a low level of EMMPRIN. In a mixed co-culture with direct cell-cell contacts, co-cultured HEp-2 cells stimulated the pro- and active MMP-2 production from fibroblasts, but not in a separated co-culture through polycarbonate membrane. Production of pro/active MMP-2 and MT1-MMP (activator of pro-MMP-2) in fibroblasts was induced by the addition of membrane fractions prepared from HEp-2 cells to the fibroblast culture, and the induction was suppressed by the EMMPRIN depletion after immunoprecipitation, signifying the participation of EMMPRIN for the induction and activation of MMP-2. Our results suggest an importance of the direct cell-cell interaction involving EMMPRIN rather than humoral factors such as cytokines for pro-MMP-2 production and activation followed by tumor progression, invasion, and metastasis in laryngeal cancer.

Antigens, CD↗